I have been accumulating odds and ends of regulatory issues over the year, and this column-the last of 2002-seems like an ideal place to present them.
United States
There are four areas in US regulations that should be briefly reviewed at this time: child-resisitant packaging, new ways to improve OTC drug actives, and issues in California regarding VOCs and Proposition 65.